Medical Condition News

RSS
New antibody with SGN-35 drug produces remission in Hodgkin lymphoma

New antibody with SGN-35 drug produces remission in Hodgkin lymphoma

Positive results from Lithera's LIPO-102 Phase IIb clinical study for abdominal fat reduction

Positive results from Lithera's LIPO-102 Phase IIb clinical study for abdominal fat reduction

Aduro receives $442,000 grant under QTDP program to support Listeria-based immunotherapy platform

Aduro receives $442,000 grant under QTDP program to support Listeria-based immunotherapy platform

BioCurex files patent for synthetic peptide in RECAF test

BioCurex files patent for synthetic peptide in RECAF test

EDP Biotech receives $244,000 grant under QTDP program for colon cancer blood test

EDP Biotech receives $244,000 grant under QTDP program for colon cancer blood test

Aeolus receives $489,000 grant under QTDP program for two lead compounds

Aeolus receives $489,000 grant under QTDP program for two lead compounds

Bristol-Myers Squibb and Simcere partner to co-develop oncology compound

Bristol-Myers Squibb and Simcere partner to co-develop oncology compound

New cyber-database enables access to information on lymphedema

New cyber-database enables access to information on lymphedema

Spectrum Pharmaceuticals receives $977,900 grant under QTDP program

Spectrum Pharmaceuticals receives $977,900 grant under QTDP program

Single injection of morphine to fight persistent pain reduces testosterone level: Research

Single injection of morphine to fight persistent pain reduces testosterone level: Research

Synageva receives $2.3 million under QTDP program

Synageva receives $2.3 million under QTDP program

SPRC receives funds from SAMHSA to focus on populations at high risk for suicide

SPRC receives funds from SAMHSA to focus on populations at high risk for suicide

Scientists discover gene variant that rewires brain's circuitry in neurological disorders

Scientists discover gene variant that rewires brain's circuitry in neurological disorders

BioSpecifics receives $426,000 grant under QTDP Program

BioSpecifics receives $426,000 grant under QTDP Program

Biogen Idec and Cardiokine terminate lixivaptan collaboration

Biogen Idec and Cardiokine terminate lixivaptan collaboration

Affymax receives $244,479.25 in funding under QTDP program

Affymax receives $244,479.25 in funding under QTDP program

PolyMedix receives $488,958 grants under QTDP program

PolyMedix receives $488,958 grants under QTDP program

Acton submits Manufacturing Supplement to FDA for AEROSPAN Inhalation Aerosol

Acton submits Manufacturing Supplement to FDA for AEROSPAN Inhalation Aerosol

New simple blood test may help diagnose Niemann-Pick type C disease

New simple blood test may help diagnose Niemann-Pick type C disease

Cerebral palsy risk doubles with IVF: Study

Cerebral palsy risk doubles with IVF: Study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.